Assessment of lipid-lowering therapy prescribing among patients with type 2 Diabetes Mellitus in Malaysian primary care settings

Dyslipidemia is a major contributor to the evolution of cardiovascular disease (CVD) among patients with type 2 diabetes mellitus (T2DM). There is a guideline recommendation to offer statin therapy to all T2DM patients between 40 to 75 years old for either primary or secondary CVD prophylaxis. Never...

Full description

Bibliographic Details
Main Authors: Elnaem, Mohamed Hassan, Nik Mohamed, Mohamad Haniki
Format: Article
Language:English
Published: International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2017
Subjects:
Online Access:http://irep.iium.edu.my/58961/
http://irep.iium.edu.my/58961/
http://irep.iium.edu.my/58961/
http://irep.iium.edu.my/58961/1/20th%20ISPOR%20EURO%20published%20abstract.pdf